MARLBOROUGH, Mass.--(BUSINESS WIRE)--Optos plc (LSE: OPTS), a world leader in retinal imaging, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...

Please provide your email address to receive an email when new articles are posted on . An OCT integrated into an ultra-widefield device provides similar visualization of retinal structural details in ...

UK-based retinal imaging company Optos, which sells a variety of optics-based systems for diagnosing eye diseases, has won a "UK PLC" award recognizing its technology development. Part-organized by ...

Rhegmatogenous retinal detachment (RRD) affects the function of the retina before and after surgical repair. We investigated ultra-wide-field autofluorescence (UAF) abnormalities in patients with ...

A new laser-based imaging technology for early detection of a range of serious eye diseases is set for a clinical study in the UK. Dunfermline-based Optos, which is listed on the London Stock Exchange ...

Optos says deal for $17.5 mln Deal to close in Q4 Optos enters $30 mln credit pact Sept 22 (Reuters) - Scottish retinal-imaging equipment firm Optos offered to buy a unit of U.S.-based Opko Health Inc ...